Impact of a new reimbursement program on hepatitis B antiviral medication cost and utilization in Beijing, China
Qiu, Qian, Li, Yan, Duan, Xiao-wan, Yang, Li-kun, Chen, Yu, Li, Hui, Wang, Li, Duan, Zhong-ping
Published in PloS one (16.10.2014)
Published in PloS one (16.10.2014)
Get full text
Journal Article
Impact of partial reimbursement on hepatitis B antiviral utilization and adherence
Qiu, Qian, Duan, Xiao-Wan, Li, Yan, Yang, Li-Kun, Chen, Yu, Li, Hui, Duan, Zhong-Ping, Wang, Li
Published in World journal of gastroenterology : WJG (28.08.2015)
Published in World journal of gastroenterology : WJG (28.08.2015)
Get full text
Journal Article
Cost-effectiveness of partial reimbursement for hepatitis B anti-viral drugs in Beijing, China: an analysis based on a retrospective cohort study
Qiu, Qian, PhD, Li, Yan, Prof, Cheng, Kai-liang, MD, Duan, Xiao-wan, MSc, Li, Hui, Prof, Yang, Li-kun, MSc, Duan, Zhong-ping, Prof, Wang, Li, Prof
Published in The Lancet (British edition) (01.10.2015)
Published in The Lancet (British edition) (01.10.2015)
Get full text
Journal Article
Impact of a New Reimbursement Program on Hepatitis B Antiviral Medication Cost and Utilization in Beijing, China: e109652
Qiu, Qian, Li, Yan, Duan, Xiao-wan, Yang, Li-kun, Chen, Yu, Li, Hui, Wang, Li, Duan, Zhong-ping
Published in PloS one (01.10.2014)
Published in PloS one (01.10.2014)
Get full text
Journal Article